ABSTRACT
Cryptosporidium spp., a significant cause of foodborne infection, have been shown to be resistant to most chemical food disinfectant agents and infective for weeks in irrigation waters and stored fresh vegetal produce. Pulsed UV light (PL) has the potential to inactivate Cryptosporidium spp. on surfaces of raw or minimally processed foods or both. The present study aimed to evaluate the efficacy of PL on viability and in vivo infectivity of Cryptosporidium parvum oocysts present on raspberries, a known source of transmission to humans of oocyst-forming apicomplexan pathogens. The skin of each of 20 raspberries was experimentally inoculated with five 10-µl spots of an oocyst suspension containing 6 × 10(7) oocysts per ml (Nouzilly isolate). Raspberries were irradiated by PL flashes (4 J/cm(2) of total fluence). This dose did not affect colorimetric or organoleptic characteristics of fruits. After immunomagnetic separation from raspberries, oocysts were bleached and administered orally to neonatal suckling mice. Seven days after infection, mice were euthanized, and the number of oocysts in the entire small intestine was individually assessed by immunofluorescence flow cytometry. Three of 12 and 12 of 12 inoculated mice that received 10 and 100 oocysts isolated from nonirradiated raspberries, respectively, were found infected. Four of 12 and 2 of 12 inoculated mice that received 10(3) and 10(4) oocysts from irradiated raspberries, respectively, were found infected. Oocyst counts were lower in animals inoculated with 10(3) and 10(4) oocysts from irradiated raspberries (92 ± 144 and 38 ± 82, respectively) than in animals infected with 100 oocysts from nonirradiated raspberries (35,785 ± 66,221, P = 0.008). PL irradiation achieved oocyst reductions of 2 and 3 log for an inoculum of 10(3) and 10(4) oocysts, respectively. The present pilot-scale evaluation suggests that PL is an effective mode of decontamination for raspberries and prompts further applicability studies in industrial contexts.
Subject(s)
Cryptosporidium parvum/radiation effects , Disinfection/methods , Oocysts/radiation effects , Rubus/parasitology , Animals , Colorimetry , Disinfectants , Flow Cytometry , Food Industry/methods , Immunomagnetic Separation , Light , Mice , Microscopy, Fluorescence , Pilot Projects , Ultraviolet Rays , WaterABSTRACT
BACKGROUND: Similar to other bacterial or protozoan infections, human cryptosporidiosis may trigger postinfectious irritable bowel syndrome (IBS)-like symptoms, a condition in which enhanced visceral perception of pain during intestinal distension plays a pivotal role. In an immunocompetent suckling rat model which mimicks features of postinfectious IBS, Cryptosporidium parvum infection induces long-lasting jejunal hypersensitivity to distension in association with intestinal activated mast cell accumulation. The aim of the present study was to explore in this model whether octreotide, a somatostatin agonist analog, could prevent the development of jejunal hypersensitivity and intestinal mast cell/nerve fiber accumulation. METHODS: Five-day-old Sprague-Dawley rats were infected with C. parvum and treated 10 days later with octreotide (50 g kg(-1) day(-1), i.p.) for 7 days. KEY RESULTS: Compared with untreated infected rats, octreotide treatment of infected rats resulted in increased weight gain [day 23 postinfection (PI)], decreased food intake (day 16 PI), and a reduction in jejunal villus alterations (day 14 PI), CD3(+) IEL (day 37 PI) and mast cell (days 37 and 50 PI) accumulations, nerve fiber densities (day 50 PI), and hypersensitivity to distension (day 120 PI). In uninfected rats, the effects of octreotide treatment were limited to higher weight gain (days 16 and 23 PI) and decreased food intake (day 23 PI) compared with uninfected-untreated rats. CONCLUSIONS & INFERENCES: Data confirms the relevance of the present rat model to postinfectious IBS studies and prompt further investigation of somatostatin-dependent regulatory interactions in cryptosporidiosis.
Subject(s)
Animals, Suckling/microbiology , Cryptosporidiosis/immunology , Cryptosporidium parvum/immunology , Hypersensitivity/immunology , Jejunum/drug effects , Jejunum/immunology , Jejunum/microbiology , Octreotide/pharmacology , Animals , Animals, Suckling/immunology , Body Weight/drug effects , Cryptosporidiosis/complications , Cryptosporidiosis/pathology , Cryptosporidium parvum/pathogenicity , Disease Models, Animal , Eating/drug effects , Female , Gastrointestinal Agents/pharmacology , Humans , Intestinal Mucosa/cytology , Intestinal Mucosa/drug effects , Intestinal Mucosa/microbiology , Irritable Bowel Syndrome/etiology , Irritable Bowel Syndrome/immunology , Irritable Bowel Syndrome/microbiology , Jejunum/pathology , Mast Cells/physiology , Rats , Rats, Sprague-DawleyABSTRACT
For around two decades, artificial snow has been used by numerous winter sports resorts to ensure good snow cover at low altitude areas or more generally, to lengthen the skiing season. Biological additives derived from certain bacteria are regularly used to make artificial snow. However, the use of these additives has raised doubts concerning the potential impact on human health and the environment. In this context, the French health authorities have requested the French Agency for Environmental and Occupational Health Safety (Afsset) to assess the health risks resulting from the use of such additives. The health risk assessment was based on a review of the scientific literature, supplemented by professional consultations and expertise. Biological or chemical hazards from additives derived from the ice nucleation active bacterium Pseudomonas syringae were characterised. Potential health hazards to humans were considered in terms of infectious, toxic and allergenic capacities with respect to human populations liable to be exposed and the means of possible exposure. Taking into account these data, a qualitative risk assessment was carried out, according to four exposure scenarios, involving the different populations exposed, and the conditions and routes of exposure. It was concluded that certain health risks can exist for specific categories of professional workers (mainly snowmakers during additive mixing and dilution tank cleaning steps, with risks estimated to be negligible to low if workers comply with safety precautions). P. syringae does not present any pathogenic capacity to humans and that the level of its endotoxins found in artificial snow do not represent a danger beyond that of exposure to P. syringae endotoxins naturally present in snow. However, the risk of possible allergy in some particularly sensitive individuals cannot be excluded. Another important conclusion of this study concerns use of poor microbiological water quality to make artificial snow.
Subject(s)
Bacteria/metabolism , Snow , Humans , Risk AssessmentABSTRACT
AIM: To assess the efficiency of a medium-pressure UV reactor under full-scale water treatment plant (WTP) conditions on the infectivity of Cryptosporidium parvum oocysts in an Naval Medical Research Institute (NMRI) suckling mice infectivity model. METHODS AND RESULTS: Six/seven-day-old mice were administered orally 2-10x10(4)Cryptosporidium parvum oocysts. Compared with nonirradiated oocysts, 40 mJ cm(-2) UV irradiation of ingested oocysts resulted 7 days later in a 3.4-4.0 log10 reduction in the counts of small intestine oocysts, using a fluorescent flow cytometry assay. CONCLUSION: Present data extend to industrial conditions previous observations of the efficiency of UV irradiation against Cryptosporidium parvum oocyst in vivo development. SIGNIFICANCE AND IMPACT OF THE STUDY: Present results suggest that in WTP conditions, a medium-pressure UV reactor is efficient in reducing the infectivity of Cryptosporidium parvum oocysts, one of the most resistant micro-organisms present in environmental waters.
Subject(s)
Cryptosporidium parvum/radiation effects , Oocysts/radiation effects , Water Microbiology , Water Purification/methods , Animals , Animals, Suckling , Cryptosporidium parvum/growth & development , Cryptosporidium parvum/pathogenicity , Flow Cytometry , Mice , PressureABSTRACT
Sarcocystis neurona is an obligate intracellular parasite that causes equine protozoal myeloencephalitis (EPM). The aim of this work was to document inhibitory activities of nitazoxanide (NTZ, [2-acetolyloxy-N-(5-nitro 2-thiazolyl) benzamide]) and new thiazolides/thiadiazolides on S. neurona in vitro development, and investigate their structure-activity relationships. S. neurona was grown in bovine turbinate cell cultures. At concentrations varying from 1.0 to 5.0mg/L, nitazoxanide and 21 of 32 second generation thiazolide/thiadiazolide agents exerted a > or =95% maximum inhibition on S. neurona development. Most active agents were either NO(2) or halogen substituted in position 5 of their thiazole moiety. In contrast, other 5-substitutions such as hydrogen, methyl, SO(2)CH(3), and CH(3) negatively impacted activity. Compared with derivatives with an acetylated benzene moiety, deacetylated compounds which most probably represent primary metabolites exhibited similar inhibitory activities. Present data provide the first evidence of in vitro inhibitory activities of nitazoxanide and new thiazolides/thiadiazolides on S. neurona development. Active halogeno-thiazolide/thiadiazolides may provide a valuable nitro-free alternative to nitazoxanide for EPM treatment depending on further evaluation of their in vivo activities.
Subject(s)
Coccidiostats/pharmacology , Sarcocystis/drug effects , Thiadiazines/pharmacology , Thiazoles/pharmacology , Animals , Cattle , Cell Line , Coccidiostats/chemistry , Structure-Activity Relationship , Thiadiazines/chemistry , Thiazoles/chemistryABSTRACT
OBJECTIVES: To evaluate the efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed Mongolian gerbil (Meriones unguiculatus) model. METHODS: Gerbils (1-month-old) were dexamethasone-immunosuppressed for 10 days and challenged orally with 10(5) Cryptosporidium parvum oocysts. From day 0 to day 12 post-infection, one group (n=14) was treated with 200 mg/kg/day nitazoxanide and another (n=15) with 100 mg/kg/day paromomycin. Infection and efficacy of nitazoxanide and paromomycin were assessed by measuring oocyst shedding in faeces, biliary tract and ileum histological examination. RESULTS: In nitazoxanide-treated and paromomycin-treated groups as compared with untreated animals (P<0.05), oocyst shedding was partially suppressed in a similar manner (P>0.05). Parasites were present in histological sections of the ileal mucosa of 16/16 infected untreated animals versus 3/14 and 6/15 in the nitazoxanide-treated and the paromomycin-treated groups, respectively (P<0.05). In addition, gall bladder infection was less frequent in nitazoxanide-treated (2/14, P<0.01) and paromomycin-treated (5/15, P=0.07) animals than in untreated controls (9/16). No histological alteration of biliary mucosa was observed in both treated and untreated infected gerbils. CONCLUSIONS: Present data support the efficacy of nitazoxanide and, to a lesser extent, paromomycin on biliary C. parvum infection in gerbils, and prompt further investigation of the potential clinical benefits of nitazoxanide in treating human biliary cryptosporidiosis.
Subject(s)
Amebicides/therapeutic use , Antiprotozoal Agents/therapeutic use , Biliary Tract Diseases/drug therapy , Cryptosporidiosis/drug therapy , Cryptosporidium parvum , Immunosuppression Therapy , Paromomycin/therapeutic use , Thiazoles/therapeutic use , Animals , Biliary Tract Diseases/parasitology , Cattle , Cryptosporidiosis/parasitology , Dexamethasone/pharmacology , Feces/parasitology , Gallbladder/parasitology , Gerbillinae , Ileum/parasitology , Immunosuppressive Agents/pharmacology , Nitro CompoundsABSTRACT
Several gene sequences of parasitic protozoa belonging to protein kinase gene families and epidermal growth factor (EGF)-like peptides, which act via binding to receptor tyrosine kinases of the EGF receptor (EGFR) family, appear to mediate host-protozoan interactions. As a clue to EGFR protein tyrosine kinase (PTK) mediation and a novel approach for identifying anticoccidial agents, activities against Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum grown in BM and HCT-8 cell cultures of 52 EGFR PTK inhibitor isoflavone analogs (dihydroxyisoflavone and trihydroxydeoxybenzoine derivatives) were investigated. Their cytotoxicities against host cells were either absent, mild, or moderate by a nitroblue tetrazolium test. At concentrations ranging from 5 to 10 microg/ml, 20 and 5 analogs, including RM-6427 and RM-6428, exhibited an in vitro inhibitory effect of > or = 95% against at least one parasite or against all three, respectively. In immunosuppressed Cryptosporidium parvum-infected Mongolian gerbils orally treated with either 200 or 400 mg of agent RM-6427/kg of body weight/day for 8 days, fecal microscopic oocyst shedding was abolished in 6/10 animals (P of <0.001 versus untreated controls) and mean shedding was reduced by 90.5% (P of <0.0001) and 92.0% (P of <0.0001), respectively, higher levels of inhibition than after nitazoxanide (200 mg/kg/day for 8 days) or paromomycin (100 mg/kg/day for 8 days) treatment (55.0%, P of <0.001, and 17.5%, P of >0.05, respectively). After RM-6427 therapy (200 mg/kg/day for 8 days), the reduction in the ratio of animals with intracellular parasites was nearly significant in ileum (P = 0.067) and more marked in the biliary tract (P < 0.0013) than after nitazoxanide or paromomycin treatment (0.05 < P < 0.004). RM-6428 treatment at a regimen of 400 mg/kg/day for 12 days inhibited oocyst shedding, measured using flow cytometry from day 4 (P < 0.05) to day 12 (P < 0.02) of therapy, when 2/15 animals had no shedding (P < 0.0001) and 11/15 were free of gut and/or biliary tract parasites (P < 0.01). No mucosal alteration was microscopically observed for treated or untreated infected gerbils. To our knowledge, this report is the first to suggest that the isoflavone class of agents has the potential for anticoccidial therapy.
Subject(s)
Coccidiostats/pharmacology , Cryptosporidium parvum/drug effects , ErbB Receptors/antagonists & inhibitors , Isoflavones/pharmacology , Neospora/drug effects , Protein Kinase Inhibitors/pharmacology , Sarcocystis/drug effects , Animals , Cattle , Cell Line , Cryptosporidium parvum/growth & development , Female , Neospora/growth & development , Sarcocystis/growth & developmentABSTRACT
Data from experimental and human cryptosporidiosis have established a major role of specific immunity in the control of Cryptosporidium parvum infection. In this work, alterations in spleen and Peyer's patch (Pp) lymphocytes were investigated in the course of a spontaneously resolutive gut cryptosporidiosis in four-day-old suckling NMRI mice infected with either 4 x 10(5) or 30 viable oocysts. Oocysts from entire small intestines, and spleen and Pp lymphocytes were examined using flow cytometry from day 7 to day 27 post-infection. Compared to uninfected animals, a 3-5 fold increase in the numbers of spleen TCR alphabeta+, CD4+, CD8+, TCR gammadelta+ and CD45R/B220+ lymphocytes was observed on day 17 post-infection in heavily infected animals. In Pp, more than ten-fold increases were observed, except for TCR gammadelta+ lymphocytes. At termination of infection, i.e. on days 21-23 after ingestion of 4 x 105 oocysts, T and B lymphocytes decreased rapidly in both organs, and remained lower than in uninfected animals on days 19-23 post-infection. In mice infected with 30 oocysts, similar alterations were observed in Pp, but not in spleen. Data suggest that in normally developing mice, clearance of gut C. parvum infection is associated with an initial increase in systemic and local lymphocyte numbers, followed by their decrease to below control levels during the recovery phase.
Subject(s)
Cryptosporidiosis/immunology , Cryptosporidium parvum/immunology , Gastrointestinal Tract/parasitology , Lymphocytes/immunology , Peyer's Patches/immunology , Spleen/immunology , Animals , Animals, Suckling , B-Lymphocytes/immunology , CD4 Antigens/analysis , CD8 Antigens/analysis , Cryptosporidiosis/parasitology , Disease Models, Animal , Leukocyte Common Antigens/analysis , Lymphocyte Count , Lymphocyte Subsets/immunology , Mice , Peyer's Patches/cytology , Receptors, Antigen, T-Cell, alpha-beta/analysis , Receptors, Antigen, T-Cell, gamma-delta/analysis , Spleen/cytology , T-Lymphocytes/immunologyABSTRACT
BACKGROUND: The association between chronic urticaria and thyroid autoimmunity has been a subject of debate. However, this link was suggested in studies searching thyroid microsomal antibodies (TMA), which are less sensitive and less specific than anti-thyroperoxidase antibodies, moreover these studies did not measure anti-TSH receptor antibodies, nor did they use a control group. As a consequence, the results of these studies are difficult to interpret. OBJECTIVE: The aim of this study was to determine whether chronic urticaria is statistically associated with thyroid autoimmunity. METHODS: In a prospective case-control study, we compared the frequency of thyroid autoantibodies in 45 patients with chronic urticaria and in 30 healthy adult volunteers; we also compared the frequency of chronic urticaria in 32 patients with thyroid diseases with thyroid autoantibodies and in 22 patients with thyroid diseases without thyroid autoantibodies. Thyroid autoantibodies and thyroid hormones were measured in all the subjects; antinuclear antibodies, rheumatoid factors, complement, IgE were assessed and routine laboratory tests were done in patients with chronic urticaria. Fisher's exact statistics were used to test our hypothesis. RESULTS: The frequency of thyroid autoantibodies was significantly higher in patients with chronic urticaria than in healthy controls (26.7%/3.3%; p < 0.01). All the patients with thyroid autoantibodies had thyroid hormone concentrations within the normal limits. The frequency of chronic urticaria was not significantly different (12.5%/9.1%; p = 0.7) in patients with thyroid diseases with or without thyroid antibodies. The rest of the biological investigations revealed only 1 patient with connective tissue disease. CONCLUSION: This study shows a significant association between chronic urticaria and thyroid autoimmunity, and that tests to detect thyroid autoantibodies are relevant in patients with chronic urticaria, whereas extensive laboratory tests are not.
Subject(s)
Autoimmunity/immunology , Thyroid Diseases/epidemiology , Thyroiditis, Autoimmune/epidemiology , Urticaria/epidemiology , Urticaria/immunology , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Autoantibodies/immunology , Case-Control Studies , Chronic Disease , Comorbidity , Female , Humans , Incidence , Male , Middle Aged , Probability , Prognosis , Prospective Studies , Reference Values , Risk Assessment , Severity of Illness Index , Sex Distribution , Thyroid Diseases/immunology , Thyroiditis, Autoimmune/immunologyABSTRACT
Sarcocystis neurona is considered a leading cause of equine protozoal myeloencephalitis (EPM), a common infectious neurological disease in horses in the Americas. EPM-like cases associated with S. neurona peptide reactive antibodies in Western blots were recently described in Normandy, France. In this report, antibodies reacting with S. neurona merozoites were detected using an agglutination assay at titers ranging from 50 to 500 in sera from 18/50 healthy horses from two farms with a previous EPM-like case. Higher values were found in older animals. Four out of six horses which traveled or stayed in the US exhibited titers over 50, a higher figure than in the group which did not travel out of France or stayed in an other European country. No correlation was found between anti-S. neurona and anti-Neospora sp. antibody titers. Data prompt further study of significance of anti-S. neurona antibodies in clinically healthy or diseased European horses, and identification of putative immunizing parasite(s) and their host(s).
Subject(s)
Antibodies, Protozoan/blood , Encephalomyelitis/parasitology , Encephalomyelitis/veterinary , Horse Diseases/parasitology , Horses/parasitology , Neospora/immunology , Sarcocystis/immunology , Animals , Antibody Specificity , Antigens, Protozoan/immunology , Coccidiosis/diagnosis , Coccidiosis/immunology , Coccidiosis/veterinary , Encephalomyelitis/immunology , Female , France , Horse Diseases/immunology , Horses/immunology , Male , Sarcocystosis/diagnosis , Sarcocystosis/immunology , Sarcocystosis/veterinary , TravelABSTRACT
Anticardiolipin antibodies (aCL) were investigated in 137 individuals chronically exposed to malaria and living in Africa and Asia. They belonged to several groups according to parasite (Plasmodium falciparum or vivax) and clinical manifestations (i.e. asymptomatic parasite carriers, acute uncomplicated attack or severe malaria episodes). aCL were measured in an enzyme immunoassay (ELISA) performed in the presence of either goat serum (aCLs) or gelatin (aCLg). In a group of 53 patients with autoimmune manifestations (i.e. antiphospholipid syndrome and/or lupus), detection of IgG but not IgM aCL was markedly reduced in the presence of gelatin. In malaria donors, high prevalence of serum co-factor-independent IgG and IgM were detected, and the presence of goat serum in the assay consistently decreased their detection. aCLg levels were found to be related to the clinical/endemic status of donors. IgG aCLg were found to be higher in asymptomatic P. falciparum carriers than in patients with uncomplicated acute or cerebral malaria. IgM aCLg were higher in the cerebral malaria group than in groups with uncomplicated acute malaria patients or asymptomatic individuals. Data suggest that using a serum co-factor independent, sensitive ELISA, aCL are commonly detected during malarial infections and related to malarial infection status.
Subject(s)
Antibodies, Anticardiolipin/immunology , Malaria, Falciparum/immunology , Malaria, Vivax/immunology , Adolescent , Adult , Africa/epidemiology , Antiphospholipid Syndrome/epidemiology , Antiphospholipid Syndrome/etiology , Antiphospholipid Syndrome/immunology , Asia/epidemiology , Autoimmunity , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Female , Humans , Lupus Erythematosus, Systemic/epidemiology , Lupus Erythematosus, Systemic/etiology , Lupus Erythematosus, Systemic/immunology , Malaria, Falciparum/complications , Malaria, Falciparum/epidemiology , Malaria, Vivax/complications , Malaria, Vivax/epidemiology , Male , Middle Aged , PrevalenceSubject(s)
Antibodies, Protozoan/analysis , Encephalomyelitis/veterinary , Horse Diseases/immunology , Sarcocystis/immunology , Sarcocystosis/veterinary , Animals , Antibodies, Protozoan/blood , Antibodies, Protozoan/cerebrospinal fluid , Encephalomyelitis/immunology , Encephalomyelitis/parasitology , Encephalomyelitis/physiopathology , Female , France , Horse Diseases/parasitology , Horse Diseases/physiopathology , Horses , Male , Sarcocystosis/immunology , Sarcocystosis/parasitology , Sarcocystosis/physiopathologyABSTRACT
Neospora caninum is considered one of the major causes of abortion in cattle in most parts of the world. In this study, the role of N. caninum was investigated in groups of aborted cattle and dairy herds from the west of France. Good correlation was found between parasite DNA detection in fetuses and serologic statuses of dams. In groups with documented abortion status and no antibodies to other pathogens, 17-45% of aborted animals were seropositive for N. caninum, and significant relationship between prevalence of Neospora antibodies and frequency of abortions was found. Neospora-associated abortions were observed all the year round, with a peak in summer. Higher ratios of seropositive abortions were found before the 6th month of gestation. In 12 herds studied in the field, serologic prevalence ranged 6-47%. No difference in age was found between seropositive and seronegative cows. Results indicate that N. caninum is an important and stable cause of abortion in cattle in France.
Subject(s)
Abortion, Veterinary/parasitology , Cattle Diseases/epidemiology , Coccidiosis/veterinary , Dog Diseases/epidemiology , Neospora/isolation & purification , Pregnancy Complications, Parasitic/veterinary , Abortion, Veterinary/epidemiology , Animals , Antibodies, Protozoan/blood , Cattle , Cattle Diseases/parasitology , Coccidiosis/epidemiology , DNA, Protozoan/analysis , Dog Diseases/parasitology , Dogs , Female , France/epidemiology , Gestational Age , Neospora/genetics , Neospora/immunology , Polymerase Chain Reaction/veterinary , Pregnancy , Pregnancy Complications, Parasitic/epidemiology , Prevalence , Seasons , Seroepidemiologic StudiesABSTRACT
A case of metronidazole- and albendazole-resistant giardiasis in a patient with the acquired immunodeficiency syndrome was successfully treated with nitazoxanide (1.5 g twice a day for 30 days). Animal studies and in vitro assays showed that the isolate was resistant to both metronidazole and albendazole and susceptible to nitazoxanide.
Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , Albendazole/pharmacology , Antiprotozoal Agents/therapeutic use , Giardiasis/drug therapy , Metronidazole/pharmacology , Thiazoles/therapeutic use , AIDS-Related Opportunistic Infections/immunology , AIDS-Related Opportunistic Infections/parasitology , Adult , Animals , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/pharmacology , Drug Resistance, Microbial , Giardia lamblia/drug effects , Giardia lamblia/isolation & purification , Giardiasis/immunology , Giardiasis/parasitology , Humans , Male , Nitro Compounds , Thiazoles/administration & dosage , Treatment OutcomeABSTRACT
The metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France was determined using a neonatal mouse model and compared with the outcome in patients after standard metronidazole therapy (0.75 g/day for 5 days). All isolates found to be clinically resistant to metronidazole (4/11) exhibited an ID50 > 120 mg/kg in the mouse model. This therefore appears to be a suitable animal model in which to explore drug failures in human giardiasis.
Subject(s)
Albendazole/pharmacology , Anti-Infective Agents/pharmacology , Antiprotozoal Agents/pharmacology , Feces/parasitology , Giardia lamblia/drug effects , Metronidazole/pharmacology , Albendazole/therapeutic use , Animals , Animals, Newborn , Anti-Infective Agents/therapeutic use , Antiprotozoal Agents/therapeutic use , Gerbillinae , Giardiasis/drug therapy , Humans , Metronidazole/therapeutic use , MiceABSTRACT
The importance of waterborne transmission of Cryptosporidium parvum to humans has been highlighted by recent outbreaks of cryptosporidiosis. The first step in a survey of contaminated water currently consists of counting C. parvum oocysts. Data suggest that an accurate risk evaluation should include a determination of viability and infectivity of counted oocysts in water. In this study, oocyst infectivity was addressed by using a suckling mouse model. Four-day-old NMRI (Naval Medical Research Institute) mice were inoculated per os with 1 to 1,000 oocysts in saline. Seven days later, the number of oocysts present in the entire small intestine was counted by flow cytometry using a fluorescent, oocyst-specific monoclonal antibody. The number of intestinal oocysts was directly related to the number of inoculated oocysts. For each dose group, infectivity of oocysts, expressed as the percentage of infected animals, was 100% for challenge doses between 25 and 1,000 oocysts and about 70% for doses ranging from 1 to 10 oocysts/animal. Immunofluorescent flow cytometry was useful in enhancing the detection sensitivity in the highly susceptible NMRI suckling mouse model and so was determined to be suitable for the evaluation of maximal infectivity risk.
Subject(s)
Cryptosporidiosis/physiopathology , Cryptosporidium parvum , Animals , Animals, Newborn , Antibodies, Monoclonal , Antigens, Protozoan/analysis , Cryptosporidiosis/transmission , Cryptosporidium parvum/isolation & purification , Cryptosporidium parvum/pathogenicity , Flow Cytometry/methods , Humans , Mice , Mice, Inbred Strains , Water/parasitologyABSTRACT
The effects of nitazoxanide and its metabolites, tizoxanide and tizoxanide glucuronide, on the development of the asexual and sexual stages of Cryptosporidium parvum in differentiated human enterocytic HCT-8 cells were evaluated in a quantitative alkaline phosphatase immunoassay. Nitazoxanide, tizoxanide and tizoxanide glucuronide were inhibitory for up to 46 h when added after sporozoite invasion (MIC50 1.2, 22.6 and 2.2 mg/L, respectively). Tizoxanide had only limited activity, but nitazoxanide and tizoxanide glucuronide strongly inhibited asexual and sexual stages, respectively.
Subject(s)
Antiprotozoal Agents/pharmacology , Cryptosporidium parvum/drug effects , Glucuronides/pharmacology , Thiazoles/pharmacology , Animals , Cell Line , Enterocytes/parasitology , Humans , Nitro CompoundsABSTRACT
OBJECTIVE: To assess the influence of fetal distress on interleukin-1beta, interleukin-6, interleukin-8 and on tumour necrosis factor-alpha blood levels in noninfected full-term neonates. STUDY DESIGN: In a multicentre prospective study, cord blood samples were obtained at time of delivery from 234 noninfected full-term neonates for the purposes of measuring serum levels of interleukin-1beta, interleukin-6, interleukin-8 and tumour necrosis factor-alpha using immunoassays. Women were classified into four groups according to the mode of delivery (vaginal delivery or caesarean section) and the presence or absence of fetal distress. The role of labour was also investigated. RESULTS: No significant relationship was found between cytokine cord blood levels and the mode of delivery. Fetal distress was associated with an increase in interleukin-6 (P = 0.01) and interleukin-8 (P < 0.001) levels, and a decrease in tumour necrosis factor-alpha (P < 0.001). Labour was also associated with a significant increase in interleukin-6 and interleukin-8 cord blood levels (P = 0.01 and P < 0.001, respectively). CONCLUSION: Fetal distress and labour were each associated with elevated interleukin-6 and interleukin-8 cord blood levels in noninfected full term neonates while only fetal distress was associated with decreased tumour necrosis factor-alpha levels.